Literature DB >> 8240180

Ocular complications of PUVA therapy.

J A See1, P Weller.   

Abstract

PUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of cataract is exceedingly rare. This paper discusses cataract formation, reviews the literature concerning the ocular complications of PUVA therapy and proposes guidelines for ocular protection during photochemotherapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240180     DOI: 10.1111/j.1440-0960.1993.tb00834.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  The effect of octreotide against oxidative damage in photosensitized conjunctiva and cornea of rabbits.

Authors:  Ulkü Demir; Tamer Demir; Nusret Akpolat
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

Review 2.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Identifying and Treating Ocular Manifestations in Psoriasis.

Authors:  Mahsaw Motlagh; Christopher Fortenbach; Howard I Maibach; Bobeck S Modjtahedi
Journal:  Am J Clin Dermatol       Date:  2021-11-03       Impact factor: 7.403

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.